Approval is for use in myelofibrosis patients with anaemia regardless of prior myelofibrosis therapy
The super-resolution optical technology will accelerate discovery in biomedical research and transform in vitro diagnostics
The VitalDose Drug Delivery Platform has been used in patient-centric dose forms in women’s health for over two decades
In 2030 over 50% of FDA approvals will involve AI discovered and developed drugs
Ayushman Bhav a comprehensive nationwide healthcare initiative ensures saturation coverage of healthcare schemes, reaching every village and town
Zilebesiran demonstrated an encouraging safety and tolerability profile in adult patients with mild-to-moderate hypertension
The biopharmaceutical leader shared its expert perspective at the Equality Lounge at the G20 Summit
Sarah currently serves as the Chief Financial Officer and Principal Accounting Officer for Criteo S.A.
Biocon Biologics recently acquired the global biosimilars business of its long-term partner Viatris
Subscribe To Our Newsletter & Stay Updated
